Temilolu O. Idowu
Vancouver, BC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Author Correction: Disrupting TSLP-TSLP receptor interactions via putative small molecule inhibitors yields a novel and efficient treatment option for atopic diseases.
Journal: EMBO molecular medicine
Published: November 07, 2024
Investigating the anti-cancer potential of pyrimethamine analogues through a modern chemical biology lens.
Journal: European journal of medicinal chemistry
Published: August 23, 2023
Disrupting TSLP-TSLP receptor interactions via putative small molecule inhibitors yields a novel and efficient treatment option for atopic diseases.
Journal: EMBO molecular medicine
Published: August 09, 2023
Ursane-Type Triterpenes, Phenolics and Phenolic Derivatives from Globimetula braunii Leaf.
Journal: Molecules (Basel, Switzerland)
Published: October 07, 2021
Overcoming β-Lactam resistance in Pseudomonas aeruginosa using non-canonical tobramycin-based antibiotic adjuvants.
Journal: Bioorganic & medicinal chemistry letters
Published: July 26, 2020
Syntheses of L-Rhamnose-Linked Amino Glycerolipids and Their Cytotoxic Activities against Human Cancer Cells.
Journal: Molecules (Basel, Switzerland)
Published: December 04, 2019
A Dimer, but Not Monomer, of Tobramycin Potentiates Ceftolozane against Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa and Delays Resistance Development.
Journal: Antimicrobial agents and chemotherapy
Published: October 11, 2019
Homodimeric Tobramycin Adjuvant Repurposes Novobiocin as an Effective Antibacterial Agent against Gram-Negative Bacteria.
Journal: Journal of medicinal chemistry
Published: September 27, 2019
Development of a nebramine-cyclam conjugate as an antibacterial adjuvant to potentiate β-lactam antibiotics against multidrug-resistant P. aeruginosa.
Journal: The Journal of antibiotics
Published: May 08, 2019
Potentiation of β-lactam antibiotics and β-lactam/β-lactamase inhibitor combinations against MDR and XDR Pseudomonas aeruginosa using non-ribosomal tobramycin-cyclam conjugates.
Journal: The Journal of antimicrobial chemotherapy
Published: March 13, 2019
Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
Journal: Drugs
Published: February 04, 2019
Heterodimeric Rifampicin-Tobramycin conjugates break intrinsic resistance of Pseudomonas aeruginosa to doxycycline and chloramphenicol in vitro and in a Galleria mellonella in vivo model.
Journal: European journal of medicinal chemistry
Published: January 15, 2019
Last Updated: 09/26/2026